Barinthus Biotherapeutics plc (BRNS)

Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.27	110.66	142.09	194.39	214.05	43.27
Cash & Short-Term Investments	74.27	110.66	142.09	194.39	214.05	43.27
Cash Growth	-30.00%	-22.12%	-26.90%	-9.19%	394.74%	278.46%
Accounts Receivable	-	-	-	5.85	0.02	0.52
Other Receivables	4.89	7.14	7.94	6.31	6.93	3.01
Receivables	4.89	7.14	7.94	12.16	6.95	3.53
Prepaid Expenses	5.41	5.86	5.4	5.89	4.61	1.08
Restricted Cash	1.4	1.74	-	-	-	-
Other Current Assets	0.8	0.34	1.47	0.61	1.15	0.03
Total Current Assets	86.78	125.74	156.91	213.04	226.77	47.9
Property, Plant & Equipment	6.58	11.76	19.4	15.71	9.09	2.77
Goodwill	-	-	12.21	12.21	12.63	-
Other Intangible Assets	14.91	21.95	25.11	28.27	31.43	-
Other Long-Term Assets	0.93	0.88	0.88	0.98	0.8	-
Total Assets	109.2	160.33	214.51	270.21	280.72	50.67
Accounts Payable	0.7	2.47	1.6	3.75	2.42	4.67
Accrued Expenses	6.68	9.53	9.21	8.06	7.88	2.54
Short-Term Debt	-	-	-	-	0.16	-
Current Portion of Leases	2.02	1.92	1.79	0.43	0.52	0.19
Current Unearned Revenue	1.4	1.74	-	-	0.18	0.25
Total Current Liabilities	10.8	15.66	12.6	12.24	11.16	7.64
Long-Term Debt	-	-	-	-	-	44.7
Long-Term Leases	9.55	10.09	11.19	8.34	6.54	1.47
Long-Term Deferred Tax Liabilities	0.32	0.44	0.57	3.75	8.08	-
Other Long-Term Liabilities	3.97	4.01	3.15	2.68	2.37	-
Total Liabilities	24.64	30.19	27.51	27	28.15	53.81
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	393.25	393.47	386.6	379.5	369.1	21.66
Retained Earnings	-293	-237.66	-176.59	-103.24	-108.59	-57.72
Comprehensive Income & Other	-15.78	-25.78	-23.23	-33.37	-8.39	-1.24
Total Common Equity	84.47	130.03	186.78	242.9	252.13	-37.3
Minority Interest	0.1	0.11	0.21	0.31	0.44	0.39
Shareholders' Equity	84.56	130.14	187	243.2	252.56	-3.15
Total Liabilities & Equity	109.2	160.33	214.51	270.21	280.72	50.67
Total Debt	11.57	12.01	12.98	8.77	7.22	46.36
Net Cash (Debt)	62.7	98.66	129.11	185.61	206.83	-3.1
Net Cash Growth	-32.89%	-23.59%	-30.44%	-10.26%	-	-
Net Cash Per Share	1.55	2.51	3.36	4.86	7.99	-0.39
Filing Date Shares Outstanding	40.83	40.34	38.92	38.34	37.19	0.03
Total Common Shares Outstanding	40.83	40.23	38.64	37.68	37.19	0.03
Working Capital	75.98	110.09	144.31	200.8	215.61	40.26
Book Value Per Share	2.07	3.23	4.83	6.45	6.78	-1447.99
Tangible Book Value	69.56	108.08	149.47	202.42	208.07	-37.3
Tangible Book Value Per Share	1.70	2.69	3.87	5.37	5.59	-1447.99
Machinery	-	7.51	6.84	5.35	2.09	1.06
Leasehold Improvements	-	9.28	8.67	3.93	0.63	0.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q